Showing 661 - 680 results of 1,769 for search '(( a (teer OR per) decrease ) OR ( 10 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.17s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664

    Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions by Alareeki, Asalah

    Published 2023
    “…HSV-2 detection in genital herpes cases was 1.21-fold (95% CI: 1.10–1.32) higher in men compared to women and decreased by 1% per calendar year. …”
    Get full text
    Get full text
    Get full text
  5. 665
  6. 666
  7. 667

    Fluctuations in cardiac stroke volume during rowing by Sejersen, Casper

    Published 2021
    “…Eight nationally competitive oarsmen (mean ± standard deviation: age 21 ± 2 years, height 190 ± 9 cm, and weight 90 ± 10 kg) rowed on an ergometer at a targeted heart rate of 130 and 160 beats per minute. …”
    Get full text
    Get full text
    Get full text
  8. 668
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey by Turner, Stuart J.

    Published 2013
    “…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…”
    Get full text
    Get full text
  14. 674
  15. 675
  16. 676
  17. 677
  18. 678

    The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar by Abushanab, Dina

    Published 2024
    “…The operational costs decreased with the developed ASP. Whereas antimicrobial consumption and resource utilisation, and their associated costs, appear to have declined with the developed ASP, with a cost saving of QAR458 (US$125) per 100-patient beds, the avoided cost was negative, by QAR4,807 (US$1,317) per 100-patient beds, adding to a total QAR4,224 (US$1,160) increase in the 100-patient beds cost after ASP development. …”
    Get full text
    Get full text
  19. 679
  20. 680